Research ArticleOriginal Research

COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry

Wilson D. Pace, Elias Brandt, Victoria A. Carter, Ku-Lang Chang, Chelsea L. Edwards, Alexander Evans, Chester Fox, Gabriela Gaona, MeiLan K. Han, Alan G. Kaplan, Rachel Kent, Janwillem W. H. Kocks, Maja Kruszyk, Chantal E. Le Lievre, Tessa Li Voti, Cathy Mahle, Barry Make, Amanda R. Ratigan, Asif Shaikh, Neil Skolnik, Brooklyn Stanley, Barbara P. Yawn and David B. Price
The Annals of Family Medicine July 2022, 20 (4) 319-327; DOI: https://doi.org/10.1370/afm.2829

Published eLetters

If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

  • Published on: (27 September 2022)
    Page navigation anchor for RE: Treatment for COPD
    RE: Treatment for COPD

    Thank you for a compelling article. While I understand that this article explored treatment in the form of drug therapy, I wonder if the authors captured data related to pulmonary rehab as another therapy option for adults with COPD. If so, will the authors report on these findings in the future?

    Competing Interests: None declared.
  • Published on: (4 September 2022)
    Page navigation anchor for Manipulating Gut Biomes In Real-Life COPD Patients Are The Key
    Manipulating Gut Biomes In Real-Life COPD Patients Are The Key
    • Deepak Gupta, Anesthesiologist, Wayne State University/Detroit Medical Center

    The practice of medicine has long been looking and doing it the wrong way and anesthesiologists like me have been no saints too. Our practice has been ignoring the role of bugs against bugs for so long that we do not even discuss their role in managing our diseases. However, it is high time that we initiate discussions about manipulating our gut biomes not only in real-life COPD patients but also in all others considering that none's eating behavior has remained the same as what it used to be among our not-too-distant forebears who had evolved fighting and surviving with many more bugs than we are exposed to. The bottom-line is this that future clinical trials as well as clinical practice among real-life COPD patients have to not only include physical barriers like masks and chemical crusaders like antibiotics but also biological guards like prebiotics-probiotics and spiritual guides like stressbusters because without holistic approach, millennials may inexplicably suffer while surviving the onslaught of evolving diseases by overlooking what their forebears had learned to pass on to their descendants over millenniums.
    Suggested Reading:
    Avalos-Fernandez M, Alin T, Métayer C, Thiébaut R, Enaud R, Delhaes L. The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis. Respir Res. 2022;23(1):214. Published 2022 Aug 23. doi:10.1186/s12931-022-02132-4
    Millares L, Monso E. The Microbiome in COPD: Emerging...

    Show More
    Competing Interests: None declared.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Get Permissions

Jump to section

Keywords